Adora Ndu, PharmD, JD, is Chief Regulatory Affairs Officer at Bridgebio Pharma. Prior to joining Bridgebio, Adora spent several years at BioMarin Pharmaceutical in various roles including as Group Vice President, and Head of Worldwide Research and Development Strategy, Scientific Collaborations and Policy, and also as Vice President, Regulatory Affairs; Policy, Research, Engagement, and International. Adora serves on the Board of Directors for DBV technologies, and the Alliance for Regenerative Medicine (ARM), and is also on the DIA Regional Advisory Council. Adora received her Doctor of Pharmacy degree from Howard University and her JD from the University of Maryland, and serves as Adjunct Faculty at Johns Hopkins University.